KRAS and mucinous adenocarcinoma: Conversely, mucinous carcinomas also harbor KRAS mutations at a higher frequency (up to 57%), which can often co-occur with TP53 mutations (which is not seen in LGSOC, where KRAS and TP53 mutations are mutually exclusive) [24].